DOI QR코드

DOI QR Code

Hypoglycemic Effect of the Functional Food Manufactured by Fermented Soybean as Main Materials in Streptozotosin - Induced Diabetic Rats

Streptozotocin 유발 당뇨쥐에 있어서 발효콩을 주원료로 한 기능성 식품의 혈당강하 효과

  • 최승필 (강원대학교 바이오산업공학부) ;
  • 최형택 ((주)신원에프아) ;
  • 이효진 (강원대학교 바이오산업공학) ;
  • 문선영 (강원대학교 바이오산업공학) ;
  • 김수현 (강원대학교 바이오산업공학) ;
  • 이범구 (강원대학교 창강제지과학연구) ;
  • 이득식 (동해대학교 외식산업학) ;
  • 함승시 (강원대학교 바이오산업공학부)
  • Published : 2004.08.01

Abstract

The present study was undertaken to evaluate the effect of functional food, which was processed with fermented soybean as main ingredient (FS), on the body weight, organ weight, plasma glucose, and plasma lipid in diabetic rats caused by streptozotocin (STZ). The body weight was decreased more slowly in the FS group than in the diabetic, and the food intake increased significantly in all diabetic groups. The food efficiency was very low in all diabetic groups, but increased significantly in the FS groups than diabetic control (p<0.05). In comparing the weight of organ, the weight of liver and kidney were increased in all diabetic groups than in the control, and decreased slightly in FS groups. The weight of heart and spleen were not different among all test groups. In the oral glucose tolerance test, the blood glucose in the diabetic group was the highest in 60 minutes. And the blood glucose in the FS group was the highest in 30 minutes, and decreased significantly after 120 minutes to the level of fasting glucose. The glucose in serum was decreased significantly in the FS groups fed the functional food for 4 weeks, compared to the diabetic control (p<0.05). Total cholesterol, triglyceride and atherogenic index (AI) in serum were significantly higher in diabetic control, compared to the normal (p<0.05), and decreased by 16.4%, 15.4% and 48.3%, respectively, in the FS fed 400 mg/kg of functional food. HDL-cholesterol was increased significantly in the FS-400, compared to the diabetic control. These results support that functional food using fermented soybean improve glucose and lipid metabolism in diabetic rats.

본 연구에서는 발효콩을 주원료로 한 기능성 식품이 streptozotocin으로 유발된 당뇨쥐의 체중, 장기무게, 혈당, 혈중 중성 지방, 혈중 콜레스테롤, HDL-콜레스테롤에 미치는 영향에 대하여 조사하였다. 기능성 식품군에서는 당뇨군에 비하여 완만한 체중 감소를 나타내었으며 식이섭취량은 모든 당뇨군에서 현저한 증가를 나타내었다. 식이효율은 모든 당뇨군에서 낮은 수치를 나타내었으나 기능성 식품의 투여로 식이효율이 당뇨군에 비해 유의적인 증가를 나타내었다(p<0.05). 장기의 중량 비교에서 간과 신장의 경우, 모든 당뇨군에서 정상군에 비하여 증가를 나타내었으며 기능성 식품의 투여로 다소 감소를 나타내었다. 심장과 비장의 무게는 모든 실험군에서 유의적인 차이를 나타내지 않았다(p<0.05). 경구 당내성 검사에서는 당뇨군에서 50분대에 혈당치가 최고에 달하였다. 기능성 식품 투여군에서는 30분대에 최고치에 이르렀으며 120분 후에는 현저하게 감소되어 거의 공복전의 수준에 도달하였다. 혈중 포도당의 수치는 기능성 식품의 4주간 투여에 의해 당뇨군에 비하여 유의적인 감소를 나타내었다(p<0.05). 혈청 중 총콜레스테롤, 중성지방, AI의 수치는 묘든 당뇨군에서 정상군에 비해 유의적으로 높은 수치를 나타내었다(p<0.05). 기능성 식품 400 mg/kg을 투여한 투여군에서는 당뇨군에 비하여 각각 16.4%, 15.4% 그리고 48.3%의 감소를 나타내었으나 시료사이의 유의적인 차이는 인정되지 않았다(p<0.05). HDL-콜레스테롤은 기능성 식품 투여에 의해 당뇨군에 비해 다소 증가를 나타내었으며, 400 mg/kg을 투여한 군에서는 정상의 수치에 근접하여 정상군과 유의적 차이가 인정되지 않아(p<0.05) 발효콩을 주원료로 한 기능성 식품이 당뇨 흰쥐의 혈중 콜레스테롤 저하와 지질대사 개선효과가 있음을 알 수 있었다.

Keywords

References

  1. Lee TH. 1999. Diagnosis and classification of diabetes mellitus.Food Ind Nutr 4: 61-65.
  2. Koivisto VA. 1993. Insulin therapy in type II diabetes.Diabetes Care 16: 29-39. https://doi.org/10.2337/diacare.16.3.29
  3. Krolewski U, Fridorich I, Grundy SM, Williams G. 1995.Glycosylated hemoglobin and the risk of microalbuminuriain patients with insulin dependent diabetes melitus. N EnglJ Med 332: 1251-1255. https://doi.org/10.1056/NEJM199505113321902
  4. Wilson TA. 2002. An early step in a long ascent: Molecularpathology of type I diabetes mellitus. Trends in Endocrinolgyand Metabolism 13: 271-272. https://doi.org/10.1016/S1043-2760(02)00596-9
  5. Hwang GW, Lee YB, Chun HW, Jung WY, Choi JW. 1998.Biological studies of Chrysanthemum coronarium(II)-Effecton free radical formation enzyme system in streptozotocin-induced rat. J Enu Sci and Tech Res Center KyungsungUniv 8: 45-59.
  6. Kim GJ, Kim YG, Kim HS. 1999. Effect of Perilla frutescensextract on the detoxification enzyme activity of hepatic lipidperoxidation in streptozotocin-induced rats. J Agri Tech& Dev Inst 3: 1-5.
  7. Jin YS, Lee YS, Lim SS, Lee EB. 2000. Pharmacologicalactivities of Paecilomyces japonica, a new type cordycepssp. Kor J Pharmacogn 31: 163-167.
  8. Joo HK, Shin YK, Lee MS. 1996. Effects of salt and alcoholon organic acids content during aging of chongkukjang. JFood Sci Technol 1: 13-23.
  9. Kim CJ, Hahn DR. 1980. The biological activity of a newglycoside, chiisanoside from Acanthopanax chiisanensis+Nakai leaves. Yakhak Hoeji 24: 123-134.
  10. Kim SY, Yoo SH, Chung SH. 2002. Antidiabetic effects of ginseng radx alba (GRA) and mori folium (MF) on multiple low dose streptozotocin-induced diabetic rats. Yakhak Hoeji46: 411-415.
  11. Shin JU, Han MJ, Lee YC, Moon YI, Kim DH. 2002. Antidiabeticactivity of Opuntia ficus-indica var. sabotan ondb/db Mice. Kor J Pharmacogn 33: 332-336.
  12. Haxsteen B. 1983. Flavonoids a class of natural products ofhigh pharmacological potency. Biochem Pharm 32: 1141-1148. https://doi.org/10.1016/0006-2952(83)90262-9
  13. Lee MS, Han MK, Lee KB, Park SS, Hong YP, An YS. 2003. Effects of chines medical material extract on plasma lipids and glucose in male rats. Korean J Food & Nutr 16: 146-151.
  14. Tham DM, Gardner CD, Haskell WL. 1998. Potential healthbenefits of dietary phytoestrogens: a review of the clinical,epidemiological, and mechanistic evidence. J Clin Endocrinol Metab 83: 2223-2235. https://doi.org/10.1210/jc.83.7.2223
  15. Menendez CM, Stoecker BJ. 1995. The role of diet in improvingglycemix control. In Nutrition and diabetes 15. Javanovic L, Peterson CM, eds. Alan R. Liss Inc., New York.
  16. Koh JB. 1998. Effects of raw soy flour (yellow and black) on serum glucose and lipid concentrations in streptozotocin-induced diabetic rats. J Korean Soc Food Sci Nutr27: 313-318.
  17. Kim MH, Kim HY, Kim WK, Kim JY, Kim SH. 2001.Effects of soy oligosaccharides on blood glucose and lipidmetabolismin stroptozotocin-induced biabetic rats. J Korean Nutr Soc 34: 3-13.
  18. Davis A, Christiansen M, Horowitz JF, Klein S, HellersteinMK, Ostlund RE. 2000. Effects of pinitol treatment on insulinaction in subjects with insulin resistance. Diabetes CareJul 23: 1000-1005. https://doi.org/10.2337/diacare.23.7.1000
  19. Nuttall FQ. 1993. Dietary fiber in the management of diabetes.Diabetes 42: 503-508. https://doi.org/10.2337/diabetes.42.4.503
  20. Kritchevsky D. 1995. Dietary protein, cholesterol ad atherosclerosis:A review of the early history. J Nutr 125: 589s-593s.
  21. Tanaka K, Aso B, Sugano M. 1984. Biliary steroid excretionin rats fed soybean protein and casein or their aminoacid mixtures. J Nutr 114: 26-32. https://doi.org/10.1093/jn/114.1.26
  22. Wiseman H. 2000. The therapeutic potential of phytoestrogens.Expert Opin Investig Drugs Aug 9: 1829-1840. https://doi.org/10.1517/13543784.9.8.1829
  23. Anderson JW. 1985. Physiologic and metabolic effects ofdiatary fiber. Federation Pro 44: 2902-2905.
  24. Ko SK, Kim JS, Choi YE, Lee SJ, Park KS, Chung SH.2002. Anti-diabetic effects of mixed water extract fromginseng radix rubra, acanthopanacis cortex, and cordyceps.Kor J Pharmacogn 33: 337-342.
  25. Lee JS, Son HS, Maeng YS, Chang YK, Ju JS. 1994. Effects of buckwheat on organ weight, glucose and lipid metabolism in streptozotocin-induced diabetic rats. Korean J Nutrition 27: 819-827.
  26. Dai S, Thompson K, Mcneill JH. 1994. One-year treatmentof streptozotocin-induced diabetic rats with vanadyl sulphate.Pharmacol Toxicol 74: 99-107.
  27. Grey NJ, Karls I, Kipnis DM. 1975. Physiological mechanismin the development of starvation ketosis in man. Diabetes24: 10-14. https://doi.org/10.2337/diabetes.24.1.10
  28. Steer KA, Sochor M, Mclean P. 1985. Renal hypertrophyin experimental diabetes changes in pentose phosphatepathway activity. Diabetes 34: 485-490. https://doi.org/10.2337/diabetes.34.5.485
  29. Gold G, Manning M, Heldt A, Nowlain R, Pettit JR, GrodskyGM. 1981. Diabetes induced with multiple subdiabetogenicdoses of streptozotocin: lack of protection by exogenoussuperoxide dismutase. Diabetes 30: 634-638. https://doi.org/10.2337/diabetes.30.8.634
  30. Goren T, Gastelli WP, Hjortland MC, Kannel WB, DawberTR. 1997. High density lipoprotein as a protective factoragainst coronary heart diesease: the fremingham study. AmJ Med 62: 707-710. https://doi.org/10.1016/0002-9343(77)90874-9
  31. Fontbonne A, Eschwege E, Cambien F, Richard JL,Ducimetiere P, Thibult N, Warnet JM, Claude JR, RosselinGE. 1989. Hypertriglyceridaemia as a risk factor of coronaryheart disease mortality in subjects with impaired glucosetolerance or diabetes. Diabetologia 32: 300-304. https://doi.org/10.1007/BF00265546
  32. Pushparaj P, Tan CH, Tan BKH. 2000. Effects of Averrhoabilimbi leaf extract on blood glucose and lipids in streptozotocin-induced diabetic rats. J Ethnopharmacology 72:69-76. https://doi.org/10.1016/S0378-8741(00)00200-2
  33. Nikkila EA, Kekki M. 1973. Plasma triglyceride transportkinetics in diabetes mellitus. Metabolism 22: 1-22. https://doi.org/10.1016/0026-0495(73)90024-3

Cited by

  1. Effects of the C3G/D3G anthocyanins-rich black soybean testa extracts on improvement of lipid profiles in STZ-induced diabetic rats vol.48, pp.4, 2015, https://doi.org/10.4163/jnh.2015.48.4.299
  2. Need for Development of a List of Meals for Diabetic Patients and Development of Barley-Based Diabetic Meals vol.51, pp.5, 2013, https://doi.org/10.6115/fer.2013.51.5.551
  3. Anti-Fatigue Effect of Traditional Korean Soybean Paste vol.06, pp.04, 2017, https://doi.org/10.12677/HJFNS.2017.64025
  4. Administration of Triticum aestivum Sprout Water Extracts Reduce the Level of Blood Glucose and Cholesterol in Leptin Deficient ob/ob Mice vol.40, pp.3, 2011, https://doi.org/10.3746/jkfn.2011.40.3.401
  5. 뽕잎 함유 대두발효물이 신생 당뇨유도쥐에 미치는 혈당강하효과 vol.37, pp.4, 2004, https://doi.org/10.3746/jkfn.2008.37.4.452
  6. Hypoglycemic Effect of Korean Traditional Soybean Paste vol.6, pp.4, 2004, https://doi.org/10.12677/hjfns.2017.64030